Quesra Latest Questions

Pinned
Quesra
Newbie
  1. You are correct that both are understandable. The only other possible everyday meaning I could think of would be ‘I see him [in my mind’s eye] last night’; that is, I am, at this very moment, imagining him last night. But it should almost always be clear from context which one is intended. ‘Correct’Read more

    You are correct that both are understandable.

    The only other possible everyday meaning I could think of would be ‘I see him [in my mind’s eye] last night’; that is, I am, at this very moment, imagining him last night. But it should almost always be clear from context which one is intended.

    ‘Correct’ doesn’t mean ‘understandable’, though. If I say ‘Me want have fooding’ it’s pretty clear what to understand from that, but it’s not anywhere near correct Standard English grammar. If you lived somewhere where you spoke a dialect of English in which this was acceptable grammar, however, then it would be correct for that dialect.

    See less
  1. The legalization and recent applications of cannabis for the treatment of certain medical conditions has led to the rise in demand for various cannabis-infused products.   These products need to be tested thoroughly, in order to maintain regulatory standards and ensure consumer safety. FollowinRead more

    The legalization and recent applications of cannabis for the treatment of certain medical conditions has led to the rise in demand for various cannabis-infused products.

     

    These products need to be tested thoroughly, in order to maintain regulatory standards and ensure consumer safety. Following this, cannabis testing services are currently being used across several industries, including healthcare, chemical, cosmetic, agriculture and food. The financial opportunity within the cannabis testing market has been analyzed across the following segments:

    • Type of Cannabis Tested
    • Type of Sample Tested
      • Flowers
      • Extracts
      • Edibles
      • Others
    • Company Size
      • Large
      • Mid-sized
      • Small
    • Key Geographical Regions
      • North America
      • Europe
      • Asia-Pacific
      • Latin America
      • Middle East and North Africa

     

    The research also includes profiles of key players (listed below) engaged in the cannabis testing market; each profile features a brief overview of the company, details related to its financial information (if available), service portfolio, recent developments, and an informed future outlook.

    • AccuScience Laboratories
    • Anresco Labs
    • CDX Analytics
    • Coastal Analytical
    • Eurofins Scientific
    • EVIO Labs
    • FoodChain ID
    • LGC
    • Medicine Creek Analytics
    • SGS
    • Tentamus

     

    Table of Contents

     

    1. Preface

      2. Executive Summary

    2. Introduction
    3. Market Landscape: Cannabis Testing Service Providers
    4. Cannabis Testing Service Providers: Company Competitiveness Analysis
    5. Cannabis Testing Service Providers: Company Profiles
    6. Market Landscape: Medicinal Cannabis Testing Product Providers

     

    1. Partnerships and Collaborations

     

    1. Global Event Analysis
    2. 10. Cannabis Testing Services Market: Market Sizing and Opportunity Analysis
    3. Concluding Remarks
    4. Executive Insights

     

    1. Appendix 1: Tabulated Data

     

    1. Appendix 2: List of Companies and Organizations

     

    To view more details on this report, click on the link:

    https://www.rootsanalysis.com/reports/cannabis-testing-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    Top 5 Companies Developing Bispecific Antibodies

    Top 10 Cell and Gene Therapy Companies

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

    See less
  1. The growing demand for complex medical devices has prompted developers to innovate and introduce biocompatible, high-performance medical device coatings that can meet the operational, clinical, and engineering requirements for these devices.   Presently, multiple types of medical device coatingRead more

    The growing demand for complex medical devices has prompted developers to innovate and introduce biocompatible, high-performance medical device coatings that can meet the operational, clinical, and engineering requirements for these devices.

     

    Presently, multiple types of medical device coating are available in the market to accommodate the multifunctionality of novel medical devices. A detailed medical coatings market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

     

    • Type of Devices Coated
    • Class I Medical Devices
    • Class II Medical Devices
    • Class III Medical Devices

     

    • Type of Coating Material
    • Polymer Coatings
    • Metal Coatings
    • Other Coatings

     

    • Company Size
    • Very Small
    • Small
    • Mid-sized
    • Large
    • Very Large

     

    • Key Geographical Region
    • North America
    • Europe
    • Asia
    • Rest of the World

     

    Key companies covered in the report

    • Advanced Coating
    • Biocoat
    • Evonik
    • Formacoat
    • Harland Medical Systems
    • Para-Coat Technologies
    • Specialty Coating Systems
    • SurModics
    • TUA Systems

     

    Table of Contents

     

    1. Preface

      2. Executive Summary

    2. Introduction
    3. Medical Device Coating Providers: Market Landscape
    4. Company Competitiveness Analysis
    5. Surface Modification Technologies and Coating Solutions: Market Landscape
    6. Product Competitiveness Analysis
    7. Medical Device Coating Providers: Company Profiles
    8. Partnerships and Collaborations
    9. Medical Coatings Providers: Pestle Analysis
    10. Market Forecast
    11. Concluding Remarks

     

    1. Executive Insights

     

    1. Appendix 1: Tabulated Data

     

    1. Appendix 2: List of Companies and Organizations

     

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/medical-device-coatings-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    Adeno-Associated Viral Vectors: Unlocking the Future Opportunities

    Modular Construction – Retrofitting Conventional Buildings

     

    Learn from our recently published whitepaper: –

    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

    See less
  1. The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost.   This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug disRead more

    The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost.

     

    This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning technology / solutions within the healthcare industry. An elaborate valuation analysis of companies that are involved in the deep learning in drug discovery and diagnostics market, based on our proprietary, multi-variable dependent valuation model to estimate the current valuation / net worth of deep learning industry players.

     

    The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:

    • Therapeutic Area
    • Oncological Disorders
    • Infectious Diseases
    • Neurological Disorders
    • Immunological Disorders
    • Endocrine Disorders
    • Cardiovascular Disorders
    • Respiratory Disorders
    • Ophthalmic Disorders
    • Musculoskeletal Disorders
    • Inflammatory Disorders
    • Other Disorders

     

    • Key Geographical Regions
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

     

    The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:

    • Aegicare
    • Aiforia Technologies
    • Ardigen
    • Berg
    • Google
    • Huawei
    • Merative
    • Nference
    • NVIDIA
    • Owkin
    • Phenomic AI
    • Pixel AI

     

    Table of Contents

     

    1. PREFACE

     

    1. EXECUTIVE SUMMARY

     

    1. INTRODUCTION

     

    1. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY

     

    1. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS

     

    1. COMPANY PROFILES

     

    1. PORTER’S FIVE FORCES ANALYSIS

     

    1. CLINICAL TRIAL ANALYSIS

     

    1. FUNDING AND INVESTMENT ANALYSIS

     

    1. START-UP HEALTH INDEXING

     

    1. COMPANY VALUATION ANALYSIS

     

    1. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY

     

    1. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS

     

    1. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS

     

    1. CONCLUDING REMARKS

     

    1. INTERVIEW TRANSCRIPTS

     

    1. APPENDIX 1: TABULATED DATA

     

    1. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

     

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html

     

    Learn from experts:  do you know about these emerging industry trends?

    Key Trends in Non-Viral Transfection Market

    Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

    See less
  1. Considering the benefits offered by cell free expression, including low cost of production, shortened production timelines and better control over the reaction environment, the adoption of cell free systems has increased over the years.   Driven by the ongoing pace of innovation and growing adoRead more

    Considering the benefits offered by cell free expression, including low cost of production, shortened production timelines and better control over the reaction environment, the adoption of cell free systems has increased over the years.

     

    Driven by the ongoing pace of innovation and growing adoption of cell free systems in the production of biomolecules, the global cell free expression market is anticipated to grow at a healthy pace in the foreseen future.

     

    The financial opportunity within the cell free market is analyzed across the following segments:

     

    • Type of Cell Free System
      • Crude Cell Lysate-based Systems
      • Reconstituted Systems

     

    • Type of Host Organism
      • Microbial Cell Free Expression System
      • Mammalian Cell Free Expression Systems
      • Plant-based Cell Free Expression Systems
      • Other Cell Free Expression Systems

     

    • Type of Expression Method
      • Coupled Transcription and Translation Method
      • Translation Method

     

    • End-User
      • Pharmaceutical and Biotechnology Companies
      • Academic and Research Institutes
      • Other End-Users

     

    • Key Geographical Regions
      • North America
      • Europe
      • Asia Pacific
    • Rest of the World

     

    The Cell Free Systems: Cell Free Expression Kits and Service Providers, 2023-2035 report features the following companies, which we identified to be key players in this domain:

    • BioLinker
    • biotechrabbit
    • CellFree Sciences
    • Creative Biolabs
    • CUSABIO
    • Daicel Arbor Biosciences
    • LenioBio
    • Promega
    • Thermo Fisher Scientific
    • Touchlight

     

    Table of Contents

     

    1. Preface

     

    1. Executive Summary

     

    1. Introduction

     

    1. Market Landscape: Cell Free Expression Service Providers

     

    1. Market Landscape: Cell Free Expression Kits

     

    1. Cell Free Expression Service Providers: Company Competitiveness Analysis

     

    1. Cell Free Expression Kits: Product Competitiveness Analysis

     

    1. Company Profiles: Cell Free Expression Service Providers

     

    1. Company Profiles: Cell Free Expression Kit Providers

     

    1. Partnerships And Collaborations

     

    1. Funding And Investment Analysis

     

    1. Patent Analysis

     

    1. Market Forecast And Opportunity Analysis

     

    1. Appendix 1: Tabulated Data

     

    1. Appendix 2: List Of Companies And Organizations

     

    For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities

    Investment Opportunities in Women’s Digital Health

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

    See less
  1. In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the stringent regulatory compliance, lack of technical expertise and access to advanced equipment, a number of drug developers prefer to outsource operations to benefit from the expertise of service proviRead more

    In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the stringent regulatory compliance, lack of technical expertise and access to advanced equipment, a number of drug developers prefer to outsource operations to benefit from the expertise of service providers, that claim to have the required competence and experience to provide fill / finish services in order to ensure the development of high-quality drug products.

     

    The financial opportunity within the aseptic fill and finish services market has been analyzed across the following segments:

    • Type of Molecule
    • Small molecules
    • Biologics

     

    • Type of Packaging Container
    • Ampoules
    • Cartridges
    • Syringes
    • Vials

     

    • Type of Drug Product
    • Antibodies
    • Cell Therapies
    • Gene Therapies
    • Oligonucleotides
    • Recombinant Proteins
    • Vaccines
    • Other Drug Products

     

    • Target Therapeutic Area
    • Autoimmune disorders
    • Oncological Disorders
    • Cardiovascular Disorders
    • Infectious Diseases
    • Other Disorders

     

    • Scale Of Operation
    • Preclinical / Clinical
    • Commercial

     

    • Company Size
    • Large
    • Mid-sized
    • Small

     

    • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and North Africa
    • Latin America

     

    The Aseptic Fill Finish Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:

    • BD Biosciences
    • AbbVie Contract Manufacturing
    • Aenova
    • APL
    • Asymchem
    • BD Biosciences
    • BioPharma Solutions
    • BioReliance
    • Boehringer Ingelheim BioXcellence
    • Catalent Biologics
    • Charles River Laboratories
    • CordenPharma
    • Delpharm
    • Fareva
    • Fresenius Kabi
    • GlaxoSmithKline
    • Hetero Drugs
    • Intas Pharmaceuticals
    • Lonza
    • Patheon
    • Pfizer CentreOne
    • Pierre Fabre
    • PiSA Farmaceutica
    • Plastikon Healthcare
    • Recipharm
    • Samsung Biologics
    • Sharp Services
    • Siegfried
    • Syngene
    • Takara Bio
    • Wacker Biotech
    • Wockhardt
    • WuXi Biologics

     

    Table of Contents

    1. PREFACE
    2. EXECUTIVE SUMMARY
    3. INTRODUCTION
    4. ASEPTIC FILL AND FINISH SERVICE PROVIDERS LANDSCAPE
    5. BIOLOGICS FILL / FINISH SERVICE PROVIDERS LANDSCAPE
    6. SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS LANDSCAPE
    7. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA
    8. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN EUROPE
    9. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC
    10. PARTNERSHIPS AND COLLABORATIONS
    11. MARKET SIZING AND OPPORTUNITY ANALYSIS
    12. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING
    13. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH
    14. CONCLUDING REMARKS
    15. EXECUTIVE INSIGHTS
    16. APPENDIX 1: TABULATED DATA
    17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

     

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    SARM1 Inhibitors: A Novel Approach Against Neurodegenerative Disorders

    TCR Therapies: An Emerging Therapeutic Modality

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

    See less
  1. The growing popularity of digital solutions has enabled the development of technological remedies, such as mobile apps, software, wearable devices and diagnostic tools that exclusively aid in improving female health and wellness.   Owing to the increased adoption rate of digital solutions and rRead more

    The growing popularity of digital solutions has enabled the development of technological remedies, such as mobile apps, software, wearable devices and diagnostic tools that exclusively aid in improving female health and wellness.

     

    Owing to the increased adoption rate of digital solutions and rise in the demand for remote healthcare services, the companies involved in the women’s digital health domain have witnessed a surge in the investment activity. Further, taking into consideration both the historical and modern scenarios, we expect the women’s digital health market to offer numerous lucrative investment opportunities.

     

    The financial opportunity within the women’s digital health market has been analyzed across the following segments:

    • Type of Solution
    • Applications / Software
    • Devices
    • Services

     

    • Therapeutic Application Area
    • Fetal Health
    • General Wellness
    • Menstrual Cycle
    • Pelvic Care
    • Reproductive Health / Fertility

     

    • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and North Africa

     

    • The Investor Series: Opportunities in Women’s Digital Health Market, features detailed profiles of the key public ventures engaged in the development of women’s digital health solutions; each profile features a brief overview of the company, details on its management team, insights from its balance sheet (if available), details on its product / service portfolio, recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis). A detailed analysis of the women’s digital health funding and women’s digital health investment activity that has taken place, since 2011.

     

    Table of Contents

     

    Excel Deliverables

    1. Innovators and Product Dataset

      2. Funding and Investment Analysis

    2. Fundamental and Technical Financial Analysis
    3. Market Forecast and Opportunity Analysis
    4. Return on Investment

    PowerPoint Deliverable

    1. Context

     

    1. Project Objectives
    2. Project Approach
    3. Executive Summary

    Section I: Introduction to Women’s Digital Health Solutions and Innovator Landscape

    1. The Women’s Digital Health Market
    2. Women’s Digital Health: Innovator Landscape
    3. Women’s Digital Health: Product Landscape and Company Health Indexing

     

    1. Value Proposition Analysis

     

    1. Company Competitiveness Analysis

     

    Section II: Analysis of Investments

    1. Funding and Investment Analysis

     

    Section III: Financial Analysis of Key Public Ventures

    1. Financial Analysis of Public Ventures

     

    1. Company Profiles of Public Ventures

     

    Section IV: Market Forecast and Opportunity Analysis

    1. Market Forecast and Opportunity Analysis

     

    Section V: Key Acquisition Targets, Business Risk Assessment and Return on Investments

    1. Key Acquisition Targets

     

    1. Business Risk Assessment

     

    1. Return on Investments

     

    1. Conclusion

     

    1. Appendices

     

    Get more details on the report https://www.rootsanalysis.com/reports/opportunities-in-women-digital–health-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule

    TIL Therapies: A New Paradigm in Cancer Treatment

     

    Learn from our recently published whitepaper: –

    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

     

     

    See less
  1. Roots Analysis has announced the addition of “Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035” report to its list of offerings.   Key Market Insights Presently, over 90 non-viral drug delivery systems developers are engaged in tRead more

    Roots Analysis has announced the addition of “Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035” report to its list of offerings.

     

    Key Market Insights

    • Presently, over 90 non-viral drug delivery systems developers are engaged in the healthcare market, located across the globe
    • Currently, more than 95 non-viral drug delivery systems are offered by several players in the healthcare domain
    • The partnership activity for non-viral drug delivery systems in the healthcare domain has grown at a CAGR of over 40%, in the past three years, 2018-2021
    • The projected future opportunity for companies engaged in this field is expected to be well distributed across type of molecule, type of biologic delivered, type of technology, target therapeutic area, type of payment model and key geographical regions.

     

    Table of Contents

     

    1. PREFACE

    1.1.                  Scope of the Report

    1.2.                  Research Methodology

    1.3.                  Market Segmentations

    1.4.                  Key Questions Answered

    1.5.                  Chapter Outlines

     

    1. EXECUTIVE SUMMARY

     

    1. INTRODUCTION

    3.1.                  Chapter Overview

    3.2.                  Need for Targeted Drug Delivery

    3.3.                  Advanced Approaches for Delivery of Drug Payloads

    3.4.                  Future Perspectives

     

    1. MARKET LANDSCAPE

    4.1.                  Chapter Overview

    4.2.                  Intracellular Drug Delivery: List of Technologies

    4.3.                  Intracellular Drug Delivery: List of Technology Developers

     

    1. KEY INSIGHTS

    5.1.                  Chapter Overview

    5.2.                  Analysis by Type of Technology

    5.3.                  Analysis by Company Size and Type of Molecule Delivered

    5.4.                  Analysis by Location of Headquarters (Region-wise) and Type of Service Provider

    5.5.                  Analysis by Company Size and Location of Headquarters

     

    1. COMPANY COMPETITIVENESS ANALYSIS

    6.1.                  Chapter Overview

    6.2.                  Assumptions / Key Parameters

    6.3.                  Methodology

    6.4.                  Company Competitiveness Analysis: Benchmarking of Portfolio Strength

    6.5.                  Company Competitiveness Analysis: Benchmarking of Partnership Strength

     

    1. COMPANY PROFILES

    7.1.                  Arcturus Therapeutics

    7.2.                  Bio-Path

    7.3.                  CureVac

    7.4.                  Entos Pharmaceuticals

    7.5.                  eTheRNA immunotherapies

    7.6.                  Matinas BioPharma

    7.7.                  MDimune

    7.8.                  PCI Biotech

     

    1. PATENT ANALYSIS

    8.1.                  Chapter Overview

    8.2.                  Scope and Methodology

    8.3.                  Intracellular Drug Delivery Technologies: Patent Analysis

    8.4.                  Intracellular Drug Delivery Technologies: Patent Valuation Analysis

     

    1. PARTNERSHIPS AND COLLABORATIONS

    9.1.                  Chapter Overview

    9.2.                  Partnership Models

    9.3.                  Intracellular Drug Delivery Technologies: List of Partnerships and Collaborations

     

    1. OPPORTUNITY ASSESSMENT FRAMEWORK: KALBACH INNOVATION MODEL, COMPETITVE ASSESSMENT FRAMEWORK AND BCG MATRIX

    10.1.                Chapter Overview

    10.2.                Kalbach Innovation Model

    10.3.                Competitive Assessment Framework

    10.4.                BCG Matrix

     

    1. MARKET FORECAST AND OPPORTUNITY ANALYSIS

    11.1.                Chapter Overview

    11.2.                Key Assumptions

    11.3.                Forecast Methodology

    11.4.                Global Non-Viral Intracellular Drug Delivery Technologies Market, 2022-2035

    11.5.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Payment Model Employed, 2022 and 2035

    11.6.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Molecule Delivered, 2022 and 2035

    11.7.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Biologic Delivered, 2022 and 2035

    11.8.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Type of Technology, 2022 and 2035

    11.9.                Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Target Therapeutic Areas, 2022 and 2035

    11.10.              Non-Viral Intracellular Drug Delivery Technologies Market: Analysis by Geography, 2022 and 2035

     

    1. CONCLUDING REMARKS

     

    1. EXECUTIVE INSIGHTS

     

    1. APPENDIX 1: TABULATED DATA

     

    1. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

     

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html

     

    News article

    Modular Facility Manufacturers Market

     

    Learn from experts:  do you know about these emerging industry trends?

    Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain

    CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

     

    See less
  1. Owing to their unique physiochemical property, the formulation of nanoparticles is extremely challenging, prompting drug developers to leverage the expertise of technology developers and service providers   Roots Analysis has announced the addition of “Nanoparticle Formulation Technologies andRead more

    Owing to their unique physiochemical property, the formulation of nanoparticles is extremely challenging, prompting drug developers to leverage the expertise of technology developers and service providers

     

    Roots Analysis has announced the addition of “Nanoparticle Formulation Technologies and Services Market, 2023-2035” report to its list of offerings.

     

    The research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this market, across different geographies. Amongst other elements, the report includes:

     

    • An executive summary of the insights captured during our research. It offers a high-level view on the current state of nanoparticle formulation market, including both technologies and services, and its likely evolution in the mid to long term.
    • A general overview of the nanoparticles, highlighting the different types of nanoparticles, methods of nanoparticle formulation, challenges associated with formulation of nanoparticles and need for outsourcing such operations.
    • A detailed assessment of the current technology landscape of nanoparticle formulations technologies, based on several relevant parameters.
    • A comprehensive assessment of the overall service providers landscape of the companies offering nanoparticle formulation service, based on several relevant parameters.
    • An insightful competitiveness analysis of nanoparticle formulation technologies developed by various stakeholders based in North America, Europe, and Asia-Pacific, Middle East and North Africa and Rest of the World.
    • A detailed competitiveness analysis of nanoparticle formulation service providers.
    • Elaborate profiles of prominent players developing technologies and offering services for nanoparticle formulation across North America, Europe and Asia-Pacific.
    • A detailed analysis of the partnerships inked between stakeholders in nanoparticle formulation market, since 2018.
    • An in-depth analysis of various patents that have been filed / granted related to nanoparticle formulation, since 2018.
    • An insightful framework evaluating types of nanoparticles based on several relevant parameters.
    • A case study of the recent technology licensing agreements, along with information on deal amounts.
    • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
    • Type of Nanoparticle Formulated
    • Organic Nanoparticles
    • Inorganic Nanoparticles
    • Carbon-based Nanoparticles

     

    • Type of Organic Nanoparticle Formulated
    • Polymeric Nanoparticles
    • Lipid Nanoparticles
    • Viral Nanoparticles
    • Protein-based Nanoparticles
    • Other Organic Nanoparticles

     

    • Scale of Operation
    • Preclinical
    • Clinical
    • Commercial

     

    • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and North Africa
    • Latin America

     

    Key companies covered in the report

    • Ascension Sciences
    • DIANT Pharma
    • ExonanoRNA
    • Nanoform
    • NanoVation Therapeutics
    • NanoVelos
    • NTT Biopharma
    • Organoid-X BioTech
    • Vaxinano

     

     

    To view more details on this report, click on the link:

    https://www.rootsanalysis.com/reports/nanoparticle-formulation-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

    Novel Cell Cytometers: Need of the Hour

     

    Learn from our recently published whitepaper: –

    Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

     

    See less
  1. Upon realizing the potential of digital biomanufacturing over traditional processes, players are actively undertaking initiatives to adopt advanced platforms to drive operational excellence, visibility, control and synchronization in bioprocessing   Roots Analysis is pleased to announce the pubRead more

    Upon realizing the potential of digital biomanufacturing over traditional processes, players are actively undertaking initiatives to adopt advanced platforms to drive operational excellence, visibility, control and synchronization in bioprocessing

     

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Digital Biomanufacturing Market, 2023-2035.”

     

    The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different regions. Amongst other elements, the report includes:

    • An executive summary of the insights captured during our research, offering a high-level view on the current state of the digital manufacturing market and its likely evolution in the mid-long term.
    • A general introduction to digital biomanufacturing, featuring a detailed discussion on various types of technologies that support digital bioprocessing. In addition, it presents the key challenges and future perspectives associated with the employment of digital technologies in the field of biomanufacturing.
    • A detailed assessment of the overall market landscape of companies offering digital manufacturing technologies (PAT, DAS, MES and digital twins), based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of company (CDMO provider and software provider), number of platforms offered, deployment options (cloud based, on-premises, corporate datacenter and hybrid), platform capabilities (process automation, bioprocess optimization and controls, process connectivity, scalability, data integration, process monitoring and visualization, performance analysis, report generation and documentation, smart manufacturing, document control, production tracking, performance analysis and data integration), software capabilities (process intelligence, data integration, real-time process monitoring, data visualization, performance analysis and control prediction, reporting and data management), type(s) of biologic(s) manufactured, other compatible platforms (artificial intelligence / machine learning / cloud based, big data, internet of things, augmented reality and virtual reality) and type of end user(s) (industry and non-industry), integrating software (enterprise resource planning (ERP), manufacturing operation management (MOM), product lifecycle management (PLM), human resource management (HRM)), type of service(s) offered (training, implementation / upgradation and general support), area(s) of application (asset / process management, clinical trials, personalized treatment, medical training, surgical planning, health monitoring and diagnosis).
    • A detailed competitiveness analysis of digital biomanufacturing technologies (PAT, DAS, MES and digital twins), based on supplier strength (in terms of years of experience and company size), technology portfolio (considering deployment options, number of platform capabilities, type of end user(s), software capabilities, area(s) of application, type(s) of twin(s)) and type(s) of biologic(s) manufactured.
    • Elaborate profiles of key players (companies offering more than one platform and established before 2012) engaged in the digital biomanufacturing domain, which are actively providing software based on PAT, DAS, MES and digital twins. Each profile includes a brief overview of the company, along with information on capabilities of digital technologies offered by these firms, recent developments and an informed future outlook.
    • A benchmark analysis highlighting the capabilities of companies (in terms of their expertise across various platforms related to the manufacturing of biologics) engaged in this domain, across key peer groups.
    • An analysis featuring information on recent partnerships inked between stakeholders engaged in this domain, based on several relevant parameters, such as year of partnership, type of partnership, type of technology, most active players (in terms of number of deals inked) and regional distribution of partnership activity, during the period 2018-2022.
    • A detailed analysis highlighting the market concentration of key industry stakeholders (companies offering more than one platform) across various regions, based on prevalent parameters, such as years of entrance, company size, type of technology, number of platforms offered and number of partnerships inked.
    • A detailed industry lifecycle analysis that indicates various stages, including emergence, growth, maturation and eventual decline for the digital biomanufacturing industry. The primary purpose of this analysis is to develop a better understanding of the current position / phase of the industry on the lifecycle chart (based on historical trends, partnership activity and various investments made by players engaged in this domain) and predict the upcoming events that are likely to drive the growth of this domain. Further, it presents short-term and long-term impacts of various key parameters that are expected to highly impact the wider adoption of digitalization in the field of biomanufacturing.
    • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
    • Type of Technology
    • Process Analytical Technology (PAT)
    • Data Analysis Software (DAS)
    • Manufacturing Execution Systems (MES)
    • Digital Twins

     

    • Deployment Options
    • Cloud-based Deployment Options
    • On-premises Deployment Options

     

    • Type(s) of Biologic(s) Manufactured
    • Antibodies
    • Cell and Gene Therapies
    • Proteins
    • Vaccines
    • Others

     

    • Geographical Regions
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and North America

     

    Key companies / organizations covered in the report

    • AspenTech
    • net
    • Dassault Systèmes
    • FUJIFILM Diosynth Biotechnologies
    • GE Healthcare
    • Körber
    • Merck
    • Sartorius
    • Thermo Fisher Scientific

     

    To view more details on this report, click on the link

    https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html

     

    Learn from experts:  do you know about these emerging industry trends?

    TCR Therapies: An Emerging Therapeutic Modality

    Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Learn more about Roots Analysis consulting services:

    Roots Analysis Consulting – the preferred research partner for global firms

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415

    Ben.johnson@rootsanalysis.com

    See less